American Lung Association Releases Annual 'State of Lung Cancer' Report

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 3, 2024.

By Lori Solomon HealthDay Reporter

MONDAY, Dec. 2, 2024 -- The lung cancer survival rate improved 26 percent in the last five years, according to the "State of Lung Cancer" report published by the American Lung Association.

The annual report examines new cases, survival, early diagnosis, surgical treatment, lack of treatment, screening rates, and insurance coverage of comprehensive biomarker testing.

According to the report, the national average of five-year survival is 28.4 percent (an increase of 26 percent over the last five years), with the best survival rates seen in Massachusetts (37.9 percent) and worst rates in Oklahoma (22.2 percent). Nationally, just over one-fourth of cases (27.4 percent) are diagnosed at an early stage, which has a five-year survival rate of 64 percent; 43 percent of cases are diagnosed at a late stage, when the survival rate is only 9 percent. One in five cases nationally (20.7 percent) undergo surgery. One in five cases nationally (20.9 percent) are untreated for reasons such as lack of provider or patient knowledge, stigma associated with lung cancer, fatalism after diagnosis, or cost of treatment. People of color who are diagnosed with lung cancer are less likely to be diagnosed early, less likely to be alive five years after diagnosis, less likely to receive surgical treatment, and more likely to receive no treatment.

"More people with lung cancer are living longer, and that is something to celebrate," Harold Wimmer, president and CEO of the American Lung Association, said in a statement. "However, lung cancer is still the leading cause of cancer deaths in the United States."

State of Lung Cancer

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-04 00:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords